Anaphylaxis rarely manifests as a vasospastic acute coronary syndrome with or without the presence of underlying coronary artery disease. The variability in the underlying pathogenesis produces a wide clinical spectrum of this syndrome. We present three cases of anaphylactic acute coronary syndrome that display different clinical variants of this phenomenon. The main pathophysiological mechanism of the allergic anginal syndromes is the inflammatory mediators released during a hypersensitivity reaction triggered by food, insect bites, or drugs. It is important to appropriately recognize and treat Kounis syndrome in patients with exposure to a documented allergen.
A cute coronary syndrome accompanying mast cell activation from allergic, hypersensitivity, or anaphylactoid reactions was fi rst described by Kounis and Zavras in 1991 and has been referred to as "allergic angina" or "allergic myocardial infarction" (1, 2) . Th e mechanism of Kounis syndrome (KS) involves release of infl ammatory cytokines through mast cell activation, which leads to coronary artery vasospasm and/or atheromatous plaque erosion or rupture (2). KS has been described with multiple conditions, including a variety of environmental exposures and drugs (3) . More recently, variant presentations of allergic angina have been described. In this case series, we describe three variable case presentations of anaphylactic ST elevations, which include ST-elevation myocardial infarction (MI) in the presence of underlying coronary artery disease and ST-elevation MI without underlying coronary artery disease (pure vasospasm). We also briefl y review the existing literature on KS.
CASE PRESENTATIONS Case 1
A 64-year-old man with known peripheral arterial disease, chronic obstructive pulmonary disease, coronary artery disease, dyslipidemia, and hypertension presented with pruritus, chest pain, dyspnea, and nausea immediately after having dinner at a restaurant including pea salad. Th e initial electrocardiogram demonstrated ST-segment elevations in leads II, III, and aVF ( Figure 1a ). Th e patient had a prior known allergic reaction (type 1) to peas and peanuts. His initial vital signs were a tem- perature of 98°F, blood pressure of 81/60 mm Hg, respiration rate of 20 breaths/minute, and pulse of 91 beats/minute. Examination disclosed wheezing, generalized erythema, and weak peripheral pulses. His hemogram and basic chemistry panel were unremarkable except for a white blood cell count of 19,500/uL. Both the creatinine kinase and troponin I levels were normal (145 U/L, normal 24-204 U/L; and <0.30 ng/ mL, normal <0.30 ng/mL, respectively).
Emergent coronary angiogram demonstrated moderate stenosis of the proximal and mid left anterior descending artery and the right coronary artery, with evidence of improvement in the stenosis with administration of intracoronary nitroglycerine ( Figure 2 ). Diagnosis of coronary vasospasm was made secondary to anaphylactic reaction from pea ingestion. Treatment for anaphylaxis was initiated with intravenous hydrocortisone, diphenhydramine, and famotidine with improvement in pruritus, dyspnea, and chest discomfort. Th e patient's blood pressure also improved to 120/60 mm Hg. Repeat electrocardiogram showed resolution of ST segment elevations ( Figure 1b) . He was discharged home.
Case 2
A 54-year-old man with past Lyme disease, hypertension, hyperlipidemia, and gastroesophageal refl ux disease presented after he was stung by a bee while working in the yard. He developed facial swelling and hypotension. Emergency medical services found him to be in respiratory distress associated with facial swelling. He was intubated and was administered intravenous diphenhydramine and methylprednisolone and inhaled albuterol. Th e initial electrocardiogram demonstrated ST elevations in the inferior leads ( Figure 3a) . Th e patient was started on intravenous fl uids and heparin and was transferred to our hospital. On arrival, he was found to have transient complete heart block, which resolved after administration of diphenhydramine and methylprednisolone. Coronary angiography revealed severe 3-vessel disease but no acute culprit lesion ( Figure 4 ). Based on the clinical data, coronary vasospasm as the likely cause was considered in retrospect. Th e ST elevations resolved on a repeat electrocardiogram (Figure 3b) . He was seen by a cardiothoracic surgery team and was scheduled for elective bypass surgery.
Case 3
A 75-year-old man with known diabetes mellitus, hypertension, hyperlipidemia, and abdominal aortic aneurysm presented to our hospital with dysuria and fever. His urinalysis was positive for leukocyte esterase, a few red blood cells, and multiple leucocytes. He was given intravenous ceftriaxone for suspected urinary tract infection. After the administration of ceftriaxone, he immediately developed a generalized erythematous macular rash, hypotension, and tachycardia followed by pulseless electrical activity and cardiac arrest. Advanced cardiovascular life support was employed, including the use of intravenous epinephrine per protocol. He had return of spontaneous circulation with complete neurological recovery. Th e electrocardiogram after return of the patient's spontaneous circulation revealed ST segment elevations in inferior leads (II, III, and aVF) (Figure 5a ), leading to activation of the cardiac catheterization laboratory team. Th e patient also received intravenous diphenhydramine, famotidine, and methylprednisolone. Subsequent electrocardiograms taken 5 and 15 minutes later showed normalization of ST segments (Figure 5b) . His hemogram and basic chemistry panel were normal; the creatinine kinase was 145 U/L, and troponin I, <0.30 ng/mL. Th e patient was admitted and successfully extubated after a day. His urinary tract infection resolved, and he was discharged home in a stable condition. Prior to discharge, he underwent an elective nuclear stress test, which showed a small fi xed apical anterolateral wall defect with no evidence of ischemia. 
DISCUSSION
Th ree types of KS have been previously described (4) . Type I includes patients with normal coronary arteries without predisposing factors for coronary artery disease in whom the acute allergic insult leads to coronary artery spasm with normal cardiac biomarkers or infarction with positive cardiac biomarkers. Th is variant represents a manifestation of endothelial dysfunction or microvascular angina (5) . Th e type II variant includes patients with culprit but inactive preexisting atheromatous disease, in whom the allergic insult leads to plaque erosion or rupture, leading to acute myocardial infarction or coronary vasospasm with normal cardiac enzymes (4) . Th e type III variant includes coronary artery stent thrombosis secondary to allergic reaction (4) . Th e ischemia in allergic reaction is secondary to the release of infl ammatory mediators, including histamine, tryptase, chymase, platelet-activating factor, cytokines, and prostaglandins, and leukotriene synthesis, which leads to coronary vasospasm (2). Vigorito et al previously reported a paradoxical vasoconstriction mediated by histamine-1 receptors (6) . Multiple cases of KS have been reported in the literature (7) . Our fi rst two cases were a form of type 2 KS, and the third case represented a form of type 1 KS. Th e second patient experienced transient complete heart block with anaphylaxis and is the second such report of KS associated with complete heart block described in the literature (8) .
Our cases further support KS as a distinct phenomenon. Some authors have argued against the vasospastic process being the dominant underlying pathophysiological explanation for KS. It is well known that anaphylaxis causes systemic vasodilation and decreased venous return secondary to increased vascular permeability and subsequently may lead to a depressed cardiac output, resulting in coronary hypoperfusion and myocardial damage. Th us, diff erentiating primary myocardial damage secondary to mast cell activation from global myocardial hypoperfusion can be challenging and remains an alternative potential explanation for allergic acute coronary syndrome (elec-trocardiographic ST elevations) (4) . It is important to recognize these forms of KS to provide appropriate management and care. Th e diagnosis and treatment of KS can be indeed challenging, requiring attention to both the cardiac and anaphylactic pathophysiology concurrently.
Treatment of KS requires thoughtful use of several common drugs. Morphine, an important drug for treating acute chest pain, should be avoided in KS, as it may potentially stimulate histamine release and exacerbate the pathologic cascade in KS. Beta-blockers also may potentiate coronary vasospasm if used in an acute exacerbation of KS due to an unopposed alpha adrenergic action. Epinephrine, which is used routinely for the treatment of anaphylaxis, should also be used with cautionary monitoring, as it may potentially worsen coronary vasospasm and aggravate coronary ischemia in KS (4) . Th e primary focus of treatment of KS should be directed towards the allergic insult and removal of the off ending allergens.
